261 related articles for article (PubMed ID: 22406477)
1. Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.
Yue X; Zhang Z; Liang X; Gao L; Zhang X; Zhao D; Liu X; Ma H; Guo M; Spear BT; Gong Y; Ma C
Gastroenterology; 2012 Jun; 142(7):1559-70.e2. PubMed ID: 22406477
[TBL] [Abstract][Full Text] [Related]
2. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C
Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719
[TBL] [Abstract][Full Text] [Related]
3. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
4. ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA.
Ma H; Yue X; Gao L; Liang X; Yan W; Zhang Z; Shan H; Zhang H; Spear BT; Ma C
Oncotarget; 2015 Jan; 6(2):1049-63. PubMed ID: 25473899
[TBL] [Abstract][Full Text] [Related]
5. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.
Luan F; Liu P; Ma H; Yue X; Liu J; Gao L; Liang X; Ma C
Int J Biochem Cell Biol; 2014 Oct; 55():129-35. PubMed ID: 25195714
[TBL] [Abstract][Full Text] [Related]
6. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake.
Wu Z; Ma H; Wang L; Song X; Zhang J; Liu W; Ge Y; Sun Y; Yu X; Wang Z; Wang J; Zhang Y; Li C; Li N; Gao L; Liang X; Yue X; Ma C
Cell Death Differ; 2020 May; 27(5):1693-1708. PubMed ID: 31740790
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
9. Zinc fingers and homeoboxes 2 is required for diethylnitrosamine-induced liver tumor formation in C57BL/6 mice.
Jiang J; Turpin C; Qiu GS; Xu M; Lee E; Hinds TD; Peterson ML; Spear BT
Hepatol Commun; 2022 Dec; 6(12):3550-3562. PubMed ID: 36194180
[TBL] [Abstract][Full Text] [Related]
10. ZHX2 is a repressor of alpha-fetoprotein expression in human hepatoma cell lines.
Shen H; Luan F; Liu H; Gao L; Liang X; Zhang L; Sun W; Ma C
J Cell Mol Med; 2008 Dec; 12(6B):2772-80. PubMed ID: 18194454
[TBL] [Abstract][Full Text] [Related]
11. Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis.
Hu S; Zhang M; Lv Z; Bi J; Dong Y; Wen J
Neoplasma; 2007; 54(3):207-11. PubMed ID: 17447851
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J
Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376
[TBL] [Abstract][Full Text] [Related]
13. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
14. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
15. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
[TBL] [Abstract][Full Text] [Related]
16. Transcription factorIRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway.
Zhu L; Dai L; Yang N; Liu M; Ma S; Li C; Shen J; Lin T; Wang D; Pan W; Li X
Cell Biochem Funct; 2020 Jul; 38(5):621-629. PubMed ID: 32153043
[TBL] [Abstract][Full Text] [Related]
17. Targeting genes and signaling pathways of transcriptional suppressor ZHX2 in hepatocellular carcinoma: a Chromatin Immunoprecipitation-sequencing (ChIP-seq) investigation.
Lv Z; He R; Huang M; Zhao G; Ma J; Chen G
Neoplasma; 2019 May; 66(3):437-445. PubMed ID: 30784286
[TBL] [Abstract][Full Text] [Related]
18. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
19. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
20. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
